2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Glioblastoma with Sarcomatous Component in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zheng, X | 1 |
| Jiang, F | 1 |
| Katakowski, M | 1 |
| Kalkanis, SN | 1 |
| Hong, X | 1 |
| Zhang, X | 1 |
| Zhang, ZG | 1 |
| Yang, H | 1 |
| Chopp, M | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Glioblastoma with Sarcomatous Component
| Article | Year |
|---|---|
Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Blotting, Western; Cell Hypoxia; Cell Line, Tumor; Cell Move | 2007 |